Thomas Sciascia, Chief Scientific Officer: Trevi Therapeutics TRVI Sell · Filed 24/08/16

Trade details

Type: Insider sale
Amount: $51,501.6
Shares · price: 18,660 sh · $2.76 a share
Held after: 220,315 sh
Stock: Trevi Therapeutics TRVI
Person: Thomas SciasciaChief Scientific Officer
Trade date: 24/08/16
Filed: 24/08/16
Days to filing: 0 days

Sold 7.8% of holdings

Share of holding sold: 7.8%

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/17~24/09/15

Thomas Sciascia's recent trades

Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$17.4K
2,631 sh
$17.4K
Filed 25/03/26
Traded 25/03/25
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$48.8K
16,496 sh
$48.8K
Filed 24/08/21
Traded 24/08/19
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$35.6K
12,745 sh
$35.6K
Filed 24/08/16
Traded 24/08/15
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$275
100 sh
$275
Filed 24/08/16
Traded 24/08/14
Thomas SciasciaChief Scientific Officer
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$136.1K
53,368 sh
$136.1K
Filed 24/05/31
Traded 24/05/29

Thomas Sciascia, Chief Officer — sold $51.5K of Trevi Therapeutics TRVI · 7.8% of holdings | Whalegun